Saturn V Capital Management LLC Ocular Therapeutix, Inc Transaction History
Saturn V Capital Management LLC
- $198 Billion
- Q1 2025
A detailed history of Saturn V Capital Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Saturn V Capital Management LLC holds 598,191 shares of OCUL stock, worth $4.37 Million. This represents 2.21% of its overall portfolio holdings.
Number of Shares
598,191
Previous 191,456
212.44%
Holding current value
$4.37 Million
Previous $1.64 Billion
168.17%
% of portfolio
2.21%
Previous 0.64%
Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
207Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$104 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$101 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$93.2 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$84.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$61.1 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $562M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...